These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9790359)

  • 21. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
    Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
    J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Rh-Hemolytic Disease in Neonates and Management with Early Intensive Phototherapy in the Neonatal Intensive Care Unit.
    Tewari VV; Kumar A; Singhal A; Pillai N; Prakash A; Varghese J; Kannan V
    J Trop Pediatr; 2020 Feb; 66(1):75-84. PubMed ID: 31199484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serum transferrin receptor concentration in seven fetuses with hemolytic disease.
    Kivivuori SM; Siimes MA; Andersson S; Teramo K
    Pediatr Hematol Oncol; 1999; 16(1):55-60. PubMed ID: 9932274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions.
    Li L; Huang L; Luo G; Luo Y; Fang Q
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):379-381. PubMed ID: 28600054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-protein-bound iron and free radical damage in fetuses with rhesus haemolytic disease: influence of intrauterine transfusions.
    Luykx LM; Berger HM; Geerdink J; Kanhai HH; Egberts J
    BJOG; 2004 Apr; 111(4):303-10. PubMed ID: 15008763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hemolytic disease of the newborn due to anti-Js(b).
    Gordon MC; Kennedy MS; O'Shaughnessy RW; Waheed A
    Vox Sang; 1995; 69(2):140-1. PubMed ID: 8585197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions.
    Saade GR; Moise KJ; Belfort MA; Hesketh DE; Carpenter RJ
    Fetal Diagn Ther; 1993; 8(3):161-4. PubMed ID: 8240686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular monitoring and management of erythroblastosis fetalis.
    Berkowitz RL; Chitkara U; Wilkins IA; Lynch L; Plosker H; Bernstein HH
    Am J Obstet Gynecol; 1988 Apr; 158(4):783-95. PubMed ID: 3284362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results and complications of intrauterine transfusion in fetuses with and without hydrops].
    Hájek Z; Kulovaný E; Liska K; Prokop M; Koleska T; Drbohlav P
    Ceska Gynekol; 1996 Feb; 61(1):31-5. PubMed ID: 8624593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of isoimmunized pregnancy by use of intravascular techniques.
    Barss VA; Benacerraf BR; Frigoletto FD; Greene MF; Penso C; Saltzman DH; Nadel A; Heffner LJ; Scherl JE; Doubilet PM
    Am J Obstet Gynecol; 1988 Oct; 159(4):932-7. PubMed ID: 3177548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
    Moise KJ; Ling LE; Oepkes D; Tiblad E; Verweij EJTJ; Lopriore E; Smoleniec J; Sachs UJ; Bein G; Kilby MD; Miller RS; Devlieger R; Audibert F; Emery SP; Markham K; Norton ME; Ocón-Hernández O; Pandya P; Pereira L; Silver RM; Windrim R; Streisand JB; Leu JH; Mirza A; Smith V; Schwartz LB; Tjoa ML; Saeed-Khawaja S; Komatsu Y; Bussel JB;
    N Engl J Med; 2024 Aug; 391(6):526-537. PubMed ID: 39115062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions.
    Doyle LW; Kelly EA; Rickards AL; Ford GW; Callanan C
    Obstet Gynecol; 1993 Jun; 81(6):931-5. PubMed ID: 7684516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.
    Altunyurt S; Okyay E; Saatli B; Canbahishov T; Demir N; Ozkan H
    Int J Gynaecol Obstet; 2012 May; 117(2):153-6. PubMed ID: 22342051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Report of experiences in 20 years use of intrauterine fetal transfusion in severe Rh-induced hemolytic disease of newborn].
    Schwarzlos G; Stark KH; During R; Hille M; Müller S; Plesse R; Scheunemann P; Wilken H
    Zentralbl Gynakol; 1988; 110(1):18-24. PubMed ID: 3354274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodevelopmental outcome after antenatal therapy for fetal supraventricular tachyarrhythmia: 3-year follow-up of multicenter trial.
    Miyoshi T; Maeno Y; Matsuda T; Ito Y; Inamura N; Kim KS; Shiraishi I; Kurosaki K; Ikeda T; Sago H; ;
    Ultrasound Obstet Gynecol; 2023 Jan; 61(1):49-58. PubMed ID: 36350016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.